Q Biomed Inc Revenue Growth Rates (QBIO), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Q Biomed inc   (QBIO)
 

QBIO's Revenue Growth by Quarter and Year

Q Biomed Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

QBIO Revenue (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
4th Quarter November -
3rd Quarter August -
2nd Quarter May -
1st Quarter February 0.00
FY 0.00

QBIOs Annual Revenue
Q Biomed Inc 's Revenue in the fiscal year 2022 $ 0.28 millions
Q Biomed Inc 's Revenue in the fiscal year 2021 $ 0.20 millions
Q Biomed Inc 's Revenue in the fiscal year 2019 $ 0.00 millions
Q Biomed Inc 's Revenue in the fiscal year 2018 $ 0.00 millions
Q Biomed Inc 's Revenue in the fiscal year 2017 $ 0.00 millions




QBIO Revenue first quarter 2023 Y/Y Growth Comment
Q Biomed inc in the first quarter 2023 recorded of $ 0.00 millions.

According to the results reported in the first quarter 2023, Q Biomed Inc achieved the best Revenue growth in Major Pharmaceutical Preparations industry. While Q Biomed Inc ' s Revenue meltdown of -100% ranks overall at the positon no. in the first quarter 2023.


QBIO Revenue ( Y/Y Growth %) 2023
 2022 2021 2020
4th Quarter November - -90 % 400 % -
3rd Quarter August - -40 % 150 % -
2nd Quarter May - 240 % - -
1st Quarter February - - - -
FY   - 45 % 400 % -

Financial Statements
Q Biomed Inc 's first quarter 2023 Revenue $ 0.00 millions QBIO's Income Statement
Q Biomed Inc 's first quarter 2022 Revenue $ 0.08 millions Quarterly QBIO's Income Statement


QBIO Revenue (Quarter on Quarter Growth %)

 2023
 2022 2021 2020
4th Quarter November - -66.67 % 100 % 0 %
3rd Quarter August - -82.35 % 0 % -
2nd Quarter May - 112.5 % - -
1st Quarter February - -20 % - -
FY (Year on Year)   - 45 % 400 % -


Back to QBIO Growth rate Comparisons >> Back to QBIO Growth rate Comparisons >>


Revenue first quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Revenue Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Revenue first quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Revenue Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Revenue by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Q Biomed Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


QBIO's I. Quarter Q/Q Revenue Comment
Recent accomplishment of 0.00 millions by Q Biomed inc come out even worse considering the 0.01 millions a quarter before.

Within Major Pharmaceutical Preparations industry Q Biomed inc achieved highest sequential Revenue growth. While Q Biomed Inc 's Revenue growth quarter on quarter, overall rank is .


Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


QBIO's I. Quarter Q/Q Revenue Comment
Recent accomplishment of 0.00 millions by Q Biomed inc come out even worse considering the 0.01 millions a quarter before.

Within Major Pharmaceutical Preparations industry Q Biomed inc achieved highest sequential Revenue growth. While Q Biomed Inc 's Revenue growth quarter on quarter, overall rank is .


Q Biomed Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Feb 28 2023)		 12 Months Ending
(Nov 30 2022)		 12 Months Ending
(Aug 31 2022)		 12 Months Ending
(May 31 2022)		 12 Months Ending
(Feb 28 2022)
Cumulative Revenue 12 Months Ending $ 0.00 $ 0.28 $ 0.38 $ 0.40 $ 0.27
Y / Y Revenue Growth (TTM) - - - - -
Year on Year Revenue Growth Overall Ranking # # # # #
Seqeuential Revenue Change (TTM) - -24.52 % -4.9 % 46.36 % -
Seq. Revenue Growth (TTM) Overall Ranking # 564 # 628 # 2504 # 9 # 0


Cumulative Revenue growth Comment
Q Biomed Inc realized trailing twelve months of $ 0 millions, in the Feb 28 2023, compare to Revenue of $ 0 millions a year ago.

Q Biomed inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
 0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 55
Sector # 113
S&P 500 # 564
Cumulative Revenue growth Comment
Q Biomed Inc realized trailing twelve months of $ 0 millions, in the Feb 28 2023, compare to Revenue of $ 0 millions a year ago.

Q Biomed inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 






Other Revenue Growth
Major Pharmaceutical Preparations Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
QBIO's Revenue Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue meltdown for the quarter ending Feb 28 2023 within Healthcare SectorY/Y Change %Revenue for the quarter ending Feb 28 2023
Stimcell Energetics Inc -47.39%$ -47.393 millions
Biomerica Inc -85.49%$ -85.491 millions


About Q Biomed Inc Revenue Growth Rates (QBIO), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Q Biomed Inc (CIK 1596062).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001410578-23-001458
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Q Biomed Inc ’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.